Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

University of Virginia Health System tests new device for mitral valve disease

20.04.2006


The mitral valve is an essential part of your heart. Matter of fact, you wouldn’t exist without it. The valve is essentially a small, round hole with two flaps on the top and bottom. Its job is to open and close rapidly, regulating the flow of blood between the upper and lower chambers of the heart’s left side- the main pumping chambers that send oxygen-rich red blood to your limbs and organs.



In some people, however, the mitral valve can leak, usually because of a congenital deformity or after a serious heart attack when the heart muscle itself is damaged. "Significant leakage of the mitral valve can shorten someone’s life, not to mention making it tough to go about the activities of daily living," said Dr Scott Lim, a cardiologist at the University of Virginia Health System.

For years, the standard of care for mitral valve leakage has been open-heart surgery with the patient on a bypass machine. Now, heart patients at the UVa Health System have a new, less invasive, option to get a leaky valve fixed.


The UVa Health System is part of a national, randomized clinical trial of a tiny, permanent, implanted device made out of titanium called the MitraClip, which ‘clips’ the leaky halves of the mitral valve together without major surgery. The MitraClip procedure starts with a catheter in a patient’s leg vein. The catheter, with the clip inside, is gently threaded to the heart to the part of the mitral valve that is leaking the most. Doctors then repair the valve via the catheter by putting the MitraClip clip on it with special hooks.

"The obvious advantage is that this is less invasive than open-heart surgery and patients can heal quicker," Lim said. "The procedure is done on an outpatient basis with an overnight observation. Patients can go home the very next day with no pain from open chest surgery."

Lim is the principal investigator at UVa for the trial, called EVEREST 2. He said the trial should help doctors know if the mitral valve clip is as effective as standard open- heart surgery. "We think this is as safe or safer but part of the purpose of the trial is to determine that for sure. So far, in 49 patients around the U.S. there have been no major life-threatening complications," Lim said.

General criteria for patients to be included in the trial are: over age 18 with significant mitral valve leakage and a candidate for mitral valve surgery. Patients in the study are randomized to either the MitraClip device or mitral valve surgery at UVa, and are required to have follow-up at set intervals at UVa for the study duration. For more information on the EVEREST 2 trial at UVa, contact Dr Scott Lim at (434) 924-9119 or Linda Bailes, RN, at (434) 982-1058.

Bob Beard | EurekAlert!
Further information:
http://www.virginia.edu

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>